Market News AIOpen the app

QNCX stock news · Quince Therapeutics, Inc.

Stories about Quince Therapeutics, Inc. (QNCX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for QNCX

Follow Quince Therapeutics, Inc. (QNCX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for QNCX
Free on the App Store and Google Play, or on the web.
  1. Oct 9, 2026, 8:03 AM ET · Market

    Quince Therapeutics says some leaders are leaving, new ones are coming in, and pay changes are happening.

    Neutral

    Quince Therapeutics ended its outside-director pay policy and moved its main office. The filing reports no business change, so the outlook is unchanged.

  2. Sep 24, 2026, 8:07 AM ET · Market

    An analyst at Ares Management starts with a positive outlook and shares the top 5 picks for Thursday.

    Good for QNCX

    Quince Therapeutics had Rodman & Renshaw start coverage with a Buy rating and a $70 target, which increases analyst backing for the company.